The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Sulfoximines: A Neglected Opportunity in Medicinal Chemistry
Abstract
Innovation has frequently been described as the key to drug discovery. However, in the daily routine, medicinal chemists often tend to stick to the functional groups and structural elements they know and love. Blockbuster cancer drug Velcade (bortezomib), for example, was rejected by more than 50 companies, supposedly because of its unusual boronic acid function (as often repeated: “only a moron would put boron in a drug!”). Similarly, in the discovery process of the pan‐CDK inhibitor BAY 1000394, the unconventional proposal to introduce a sulfoximine group into the lead series also led to sneers and raised eyebrows, since sulfoximines have seldom been used in medicinal chemistry. However, it was the introduction of the sulfoximine group that finally allowed the fundamental issues of the project to be overcome, culminating in the identification of the clinical sulfoximine pan‐CDK inhibitor BAY 1000394. This Minireview provides an overview of a widely neglected opportunity in medicinal chemistry—the sulfoximine group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Griffith, O. W., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35980-5 · Cited by 1,683
Role of sulfur chirality in the chemical processes of biology
Bentley, R. (2005) · Chemical Society Reviews · doi:10.1039/b418284g · Cited by 540
Discovery and Characterization of Sulfoxaflor, a Novel Insecticide Targeting Sap-Feeding Pests
Zhu, Y., Loso, M. R., Watson, G. B., Sparks, T. C., Rogers, R. B., Huang, J. X., Gerwick, B. C., Babcock, J. M., Kelley, D., Hegde, V. B., et al. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf102765x · Cited by 382
Biological characterization of sulfoxaflor, a novel insecticide
Babcock, J. M., Gerwick, C. B., Huang, J. X., Loso, M. R., Nakamura, G., Nolting, S. P., Rogers, R. B., Sparks, T. C., Thomas, J., Watson, G. B., et al. (2011) · Pest Management Science · doi:10.1002/ps.2069 · Cited by 228
Novel nicotinic action of the sulfoximine insecticide sulfoxaflor
Watson, G. B., Loso, M. R., Babcock, J. M., Hasler, J. M., Letherer, T. J., Young, C. D., Zhu, Y., Casida, J. E., & Sparks, T. C. (2011) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2011.01.009 · Cited by 187
l-S,R-buthionine sulfoximine: historical development and clinical issues
Bailey, H. H. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00164-6 · Cited by 178
Siemeister, G., Lücking, U., Wengner, A. M., Lienau, P., Steinke, W., Schatz, C. A., Mumberg, D., & Ziegelbauer, K. B. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0286 · Cited by 176
Self-citationGriffith, O. W., Anderson, M. E., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34188-1 · Cited by 170
Manning, J. M., Moore, S., Rowe, W. B., & Meister, A. (1969) · Biochemistry · doi:10.1021/bi00834a066 · Cited by 166
Cited by
Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Murray, P. R. D., Cox, J. H., Chiappini, N. D., Roos, C. B., McLoughlin, E. A., Hejna, B. G., Nguyen, S. T., Ripberger, H. H., Ganley, J. M., Tsui, E., et al. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00374 · Cited by 588
Frings, M., Bolm, C., Blum, A., & Gnamm, C. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.091 · Cited by 501
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
Zhu, W., Wang, J., Wang, S., Gu, Z., Aceña, J. L., Izawa, K., Liu, H., & Soloshonok, V. A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.026 · Cited by 493
Sulfur-Containing Agrochemicals
Devendar, P., & Yang, G.-F. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0169-9 · Cited by 481
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429
Photocatalysis in the Life Science Industry
Candish, L., Collins, K. D., Cook, G. C., Douglas, J. J., Gómez-Suárez, A., Jolit, A., & Keess, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00416 · Cited by 428
Lücking, U. (2019) · Organic Chemistry Frontiers · doi:10.1039/c8qo01233d · Cited by 364
Self-citationFoote, K. M., Nissink, J. W. M., McGuire, T., Turner, P., Guichard, S., Yates, J. W. T., Lau, A., Blades, K., Heathcote, D., Odedra, R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01187 · Cited by 332
Recent Developments in Ruthenium-Catalyzed C–H Arylation: Array of Mechanistic Manifolds
Nareddy, P., Jordan, F., & Szostak, M. (2017) · ACS Catalysis · doi:10.1021/acscatal.7b01645 · Cited by 290
Sulfonimidamides in Medicinal and Agricultural Chemistry
Chinthakindi, P. K., Naicker, T., Thota, N., Govender, T., Kruger, H. G., & Arvidsson, P. I. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610456 · Cited by 271
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
Shagufta, & Ahmad, I. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.056 · Cited by 263
von Nussbaum, F., Li, V. M. ‐., Allerheiligen, S., Anlauf, S., Bärfacker, L., Bechem, M., Delbeck, M., Fitzgerald, M. F., Gerisch, M., Gielen‐Haertwig, H., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500131 · Cited by 65
Metadata
- Authors
- Lücking, U.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2013-08-09
- Volume
- 52
- Issue
- 36
- Pages
- 9399-9408
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2154119901
- Cited by
- 672
- References
- 26
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.